Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

The Independent UK

Elderly Nursing Home Residents Denied Life-Saving COVID Treatment, Study Finds

Inadequate use of antiviral medication led to avoidable mortality, with Paxlovid underutilized

Zenger

Panadol maker plans sweeping job cuts a year after being spun off from GSK

Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Should You Buy the Dip in Pfizer Stock? Here's What You Need to Know

US stock markets delivered stellar returns in the first half of the year and the Nasdaq 100 had its best first-half performance ever. However, Pfizer, whose COVID-19 vaccine made the company a household name recently fell to a 52-week low. Why is Pfizer stock going down and should you buy…

Barchart

Should Value Investors Watch Pfizer (PFE)?

Pfizer (PFE) is spending its COVID-19 cash flows on meaningful growth avenues. However, given a recent downgrade, should value investors still be excited about this stock? Let’s look at the trends of its financial metrics to get an idea….

StockNews.com

‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest

The Guardian - UK

2 Unusually Active Options to Buy/Sell Not Named Rivian

Rivian’s strong sales results drove the unusual options activity in Friday trading. For those who aren’t enamored with the electric vehicle manufacturer’s business, there are, pardon the pun, other options.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

Daily Mirror

AbbVie (ABBV) vs. Pfizer (PFE) - Which Pharma Stock Comes out on Top?

With the growing prevalence of chronic conditions, an aging population, widespread adoption of digital technologies, and several R&D efforts, the pharmaceutical industry is poised for exponential growth and expansion. So, let’s compare leading pharma stocks AbbVie (ABBV) and Pfizer (PFE) to identify which is a better investment now. Keep reading….

StockNews.com

The plan to dodge another tripledemic

Vaccines to stave off the flu, a new COVID variant and now, respiratory syncytial virus could help avert another tripledemic this fall. Unless the public is too crisis-fatigued to care.

Axios

Up to 10,000 Britons could take part in cancer vaccine trials

Participants could receive groundbreaking treatment after the Government signed an agreement with a leading pharmaceutical company.

The Independent UK

A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available

Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.

Inverse

UK regulator sued for not investigating Covid vaccine ‘misinformation’

Case brought against General Medical Council for failure to look into claimed links to heart problems and deaths

The Guardian - UK

EU Commission Secures Vaccine Production Capacity For Future Crises

Pfizer and European pharmaceutical firms to stockpile vaccines for rapid response, raising concerns over equity

Zenger

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Tech Stocks Undercut by Sharp Rise in T-note Yields on Hawkish Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.31%. Stocks are being undercut by today’s hawkish Powell comments,...

Barchart

Markets Today: Stocks Higher on Positive U.S. Bank Stress Tests

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.23%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.21%. Stocks are higher this morning on U.S. economic resilience as reflected in today’s U.S. economic reports. Also, there is optimism about the U.S. banking system...

The Independent UK

Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says

Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first

The Conversation

'The dirty disease' – both smokers and non-smokers get lung cancer. They face stigma on top of illness

Earlier this year, federal health minister Mark Butler announced a new national Lung Cancer Screening Program. The first of its kind for lung cancer, the screening program will open initially to current and former smokers aged 50 to 70 years by July 2025. It aims to save lives by detecting…

Get all your
news in one place.

100's of premium titles.
One news app.

Newsroom.co.nz

Supply of medicines to NZ threatened after vaccine disclosure – Ombudsman

After the Government mistakenly released confidential information about Covid-19 vaccines, the health ministry says it was 'made clear' this could have implications for broader pharmaceutical and therapeutic supply.

The Hindu

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24.

Newsroom.co.nz

What Covid has in store for winter

Pharmaceutical giant Pfizer say forewarned is forearmed when it comes to potentially spiking Covid numbers in the winter months

Daily Mirror

Two million Brits have been taking antidepressants for five years or more

Brits' long-term dependence on anti-depressants has been laid bare as figures show a quarter of people using the drugs have been taking them for more than five years

The Guardian - AU

Warren Entsch denies he helped LNP donor get Pfizer vaccine during supply crisis

Allegation raised in parliament that MP arranged for property developer Alex Sekler to travel to Torres Strait for Covid jab referred to state corruption watchdog

AAP

MP denies quid pro quo over COVID-19 jab for donor

The federal health minister has accused Liberal MP Warren Enstch of allowing a wealthy donor to use a COVID-19 vaccine dose intended for Indigenous people.

Tribune News Service

COVID boosters should be updated to target XBB strain, US health advisers say

COVID-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide the best protection during the U.S. fall and winter season, health regulators said.

1 … 23 24 25 26

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.